| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.03 |